₹
257.70
Oct 21
Business Description
Indo US Bio-Tech Ltd
ISIN : INE250Z01010
Description
Financial Strength
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Equity-to-Asset | 0.69 | |||||
Debt-to-Equity | 0.33 | |||||
Debt-to-EBITDA | N/A | |||||
Interest Coverage | N/A | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | 20.89 | |||||
Beneish M-Score | -1.43 | |||||
WACC vs ROIC |
Growth Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 9.7 | |||||
3-Year EBITDA Growth Rate | 14.6 | |||||
3-Year EPS without NRI Growth Rate | 6.8 | |||||
3-Year FCF Growth Rate | -42.8 | |||||
3-Year Book Growth Rate | 9.4 |
Momentum Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 34.33 | |||||
9-Day RSI | 34.95 | |||||
14-Day RSI | 39.17 | |||||
6-1 Month Momentum % | 26.36 | |||||
12-1 Month Momentum % | 41.01 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 3.81 | |||||
Quick Ratio | 1.91 | |||||
Days Inventory | 123.26 | |||||
Days Sales Outstanding | 113.39 | |||||
Days Payable | 42.93 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -11.3 | |||||
Shareholder Yield % | 0.1 |
Profitability Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 28.37 | |||||
Operating Margin % | 15.51 | |||||
Net Margin % | 11.33 | |||||
FCF Margin % | -9.87 | |||||
ROE % | 27.57 | |||||
ROA % | 16.62 | |||||
ROIC % | 24.52 | |||||
ROC (Joel Greenblatt) % | 24.29 | |||||
ROCE % | 29.63 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 62.7 | |||||
PE Ratio without NRI | 62.7 | |||||
Shiller PE Ratio | 91.61 | |||||
PEG Ratio | 2.3 | |||||
PS Ratio | 7.09 | |||||
PB Ratio | 13.42 | |||||
Price-to-Tangible-Book | 13.42 | |||||
EV-to-EBIT | 51.85 | |||||
EV-to-EBITDA | 48.07 | |||||
EV-to-Revenue | 7.27 | |||||
EV-to-FCF | -72.6 | |||||
Price-to-DCF (Earnings Based) | 2.41 | |||||
Price-to-Peter-Lynch-Fair-Value | 2.51 | |||||
Price-to-Graham-Number | 6.12 | |||||
Price-to-Net-Current-Asset-Value | 17.38 | |||||
Earnings Yield (Greenblatt) % | 1.93 | |||||
FCF Yield % | -1.39 | |||||
Forward Rate of Return (Yacktman) % | 19.26 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Indo US Bio-Tech Ltd Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil ₹) | 728.363 | ||
EPS (TTM) (₹) | 4.11 | ||
Beta | 0.54 | ||
Volatility % | 40.67 | ||
14-Day RSI | 39.17 | ||
14-Day ATR (₹) | 20.08478 | ||
20-Day SMA (₹) | 275.9525 | ||
12-1 Month Momentum % | 41.01 | ||
52-Week Range (₹) | 180 - 349.8 | ||
Shares Outstanding (Mil) | 20.05 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 5 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Indo US Bio-Tech Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Indo US Bio-Tech Ltd Stock Events
Event | Date | Price(₹) | ||
---|---|---|---|---|
No Event Data |
Indo US Bio-Tech Ltd Frequently Asked Questions
What is Indo US Bio-Tech Ltd(BOM:541304)'s stock price today?
When is next earnings date of Indo US Bio-Tech Ltd(BOM:541304)?
Does Indo US Bio-Tech Ltd(BOM:541304) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |